Skip to main content
Equibles

Carlyle Group Inc.

Position in SPRB — Spruce Biosciences, Inc.

CIK 1527166 WASHINGTON, DC
Back to SPRB Full portfolio

Position in SPRB

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$2,085,480
-$438,337 QoQ
Shares Held
38,620
0.0% QoQ
Ownership
1.34%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#16
of 63 holders
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in SPRB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Carlyle Group Inc. holds $44,066,764 across 6 Biotechnology names. SPRB ranks #2 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PHAT
Phathom Pharmaceuticals, Inc.
 3,496,808 $37,940,366
2 SPRB
Spruce Biosciences, Inc.
This page 		38,620 $2,085,480
3 ACET
Adicet Bio, Inc.
 184,295 $1,592,308
4 OKUR
OnKure Therapeutics, Inc.
 269,895 $1,230,721
5 QTTB
Q32 Bio Inc.
 60,363 $769,024
6 JSPR
Jasper Therapeutics, Inc.
 1,066,189 $448,865

All Filings in SPRB

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,085,480 38,620
2026-03-31 $2,523,817 38,620
2025-12-31 $3,364,188 38,620
2025-09-30 $25,923,836 2,896,518
2025-03-31 $839,990 2,896,518
2024-12-31 $1,216,537 2,896,518
2024-09-30 $1,375,846 2,896,518
2024-06-30 $1,500,396 2,896,518
2024-03-31 $2,276,663 2,896,518
2023-12-31 $8,486,797 2,896,518
2023-09-30 $6,546,130 2,896,518
2023-06-30 $6,227,513 2,896,518
2023-03-31 $6,401,304 2,896,518